Data Year:

For its 2025 fiscal year, Alignment Healthcare, Inc., listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2025
Name And Title Total Compensation Pay Rank By Title In Insurance industry
John Kao
Chief Executive Officer
Total Compensation $11,278,583 View details Pay Rank By Title In Insurance industry #47 View more
Thomas Freeman
Former Chief Financial Officer
Total Compensation $2,886,801 View details Pay Rank By Title In Insurance industry #71 View more
Dawn Maroney
President
Total Compensation $5,444,832 View details Pay Rank By Title In Insurance industry #15 View more
Hyong (Ken) Kim M.D.
Chief Medical Officer
Total Compensation $3,129,021 View details Pay Rank By Title In Insurance industry #15 View more
James M. Head
Chief Financial Officer
Total Compensation $3,325,836 View details Pay Rank By Title In Insurance industry #58 View more
Christopher Joyce
Chief Legal & Administrative Officer
Total Compensation $3,049,447 View details Pay Rank By Title In Insurance industry #6 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at Alignment Healthcare, Inc. as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. Alignment Healthcare, Inc. income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. Alignment Healthcare, Inc. annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
John Kao
Chief Executive Officer
Total Cash $2,778,149 Equity $8,500,014 Other $420 $11,278,583
Thomas Freeman
Former Chief Financial Officer
Total Cash $978,596 Equity $1,899,990 Other $8,215 $2,886,801
Dawn Maroney
President
Total Cash $1,730,406 Equity $3,700,006 Other $14,420 $5,444,832
Hyong (Ken) Kim M.D.
Chief Medical Officer
Total Cash $1,314,585 Equity $1,800,016 Other $14,420 $3,129,021
James M. Head
Chief Financial Officer
Total Cash $823,918 Equity $2,500,010 Other $1,908 $3,325,836
Christopher Joyce
Chief Legal & Administrative Officer
Total Cash $1,285,435 Equity $1,750,012 Other $14,000 $3,049,447
For its 2025 fiscal year, Alignment Healthcare, Inc., listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
John Kao CEO Pay $11,278,569 Median Employee Pay $71,260 CEO Pay Ratio 158:1
For its 2024 fiscal year, Alignment Healthcare, Inc., listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
David Hodgson Total Cash $270,000
Jacqueline Kosecoff Total Cash $268,125
Jeffrey Margolis Total Cash $212,500
Jody Bilney Total Cash $258,125
Joseph Konowiecki Total Cash $601,411
Margaret McCarthy Total Cash $296,875
Mark McClellan Total Cash $251,875
Robbert Vorhoff Total Cash $266,875
Thomas Carella Total Cash $235,625
Yon Jorden Total Cash $263,750
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.